Helicobacter pylori surface and enzyme thiol groups

Helicobacter pylori surface and enzyme thiol groups represent a collective therapeutic target for bismuth-based antimicrobial agents (StatPearls, 2023). These thiol (sulfhydryl) groups are essential components of numerous bacterial enzymes, including urease, which is critical for the survival of H. pylori in the acidic environment of the stomach (PubMed, 10961714). Bismuth compounds, such as bismuth subsalicylate, interact with these groups to form stable complexes, thereby inhibiting enzymatic activity and disrupting metabolic pathways (Journal of Inorganic Biochemistry, 1999). Additionally, the binding of bismuth to surface-exposed thiols compromises the bacterial cell wall and interferes with the pathogen's ability to adhere to gastric epithelial cells (PubMed, 10961714). This multi-targeted approach helps to eradicate the infection and is particularly effective in combination therapies for treating peptic ulcers and preventing gastric cancer. Because bismuth targets multiple sites simultaneously, the development of bacterial resistance is significantly less common compared to conventional antibiotics (StatPearls, 2023). The interaction is characterized by high affinity, allowing bismuth to effectively compete for these sites even at relatively low concentrations in the gastric lumen.

Other names

H. pylori sulfhydryl groupsBacterial thiol groupsBismuth-binding sites in H. pyloriHelicobacter pylori thiol-containing proteins

Bismuth compounds exert their antimicrobial effect by binding with high affinity to the thiol (sulfhydryl) groups of various H. pylori enzymes and surface proteins (PubMed, 10961714). This binding leads to the inactivation of key metabolic enzymes, such as urease and alcohol dehydrogenase, and disrupts the structural integrity of the bacterial cell wall, ultimately resulting in bacterial lysis and reduced adherence to the gastric mucosa (Journal of Inorganic Biochemistry, 1999).